Searchable abstracts of presentations at key conferences in endocrinology

ea0077p39 | Metabolism, Obesity and Diabetes | SFEBES2021

Longitudinal clinical trajectory analysis of individuals before and after diagnosis of Type 2 Diabetes Mellitus (T2DM) indicates that vascular problems and asthma pre-date diabetes diagnosis by many years

Heald Adrian , Fachim Helene , Stedman Mike , Gibson Martin , Anderson Simon G , Peng Yonghong , Ollier WiIliam

Introduction: Type 2 diabetes mellitus (T2DM) frequently associates with increasing multi-morbidity/treatment complexity. Some headway has been made to identify genetic and non-genetic risk factors for T2DM. However longitudinal clinical histories of individuals both before and after diagnosis of T2DM are likely to provide additional insight into both diabetes aetiology/further complex trajectory of multi-morbidity.Methods: This study utilised diabetes p...

ea0101op-10-04 | Oral Session 10: Thyroid dysfunction-2 | ETA2024

The relation between circulating free thyroxine (FT4) and thyroid stimulating hormone (TSH) levels is very different in people taking levothyroxine vs those who are on no thyroid hormone replacement

Heald Adrian , Stedman Mike , Okosieme Onyebuchi , Premawardhana Lakdasa , Dayan Colin , Taylor Peter

Introduction: There continues to be much discussion around optimization of thyroid hormone status in hypothyroid individuals. The ideal therapeutic goal in hypothyroidism would be to restore clinical and biochemical euthyroidism via physiologic thyroid hormone replacement. This concept may seem straightforward, but there are subtleties that have only recently been recognized. We here looked the way that FT4 and TSH related to each other in a large laboratory sample of people w...

ea0101ps1-07-02 | Case reports | ETA2024

Liothyronine and a sudden unexplained death: cause or coincidence?

Bahl Suhani , Taylor Peter , Okosieme Onyebuchi , Stedman Mike , Heald Adrian , Premawardhana Lakdasa , Dayan Colin

Introduction: Levothyroxine monotherapy is the standard treatment for hypothyroidism; it is safe and inexpensive, restores thyroid function tests to within the reference range, and improves symptoms in most patients. However, some patients require Liothyronine (LT3) to improve symptoms, and there is less safety data available for this. Here we report a case of sudden death in a patient using Liothyronine and present a safety data review for Liothyronine and Levothyroxine using...

ea0104p9 | Adrenal & Cardiovascular | SFEIES24

Difference in the relation between circulating free thyroxine (FT4) and thyroid stimulating hormone (TSH) levels for people taking levothyroxine compared with those who are on no thyroid hormone replacement

Heald Adrian , Taylor Peter , Dayan Colin , Chaudhury Nadia , Okosieme Buchi , Lakdasa Premawardhana Lakdasa , Stedman Mike

Introduction: There continues to be much discussion around optimization of thyroid hormone status in hypothyroid individuals. We looked the way that FT4/TSH relate to each other in people who underwent a check of thyroid function (TFT) split between those on levothyroxine replacement (monitoring-test) and those who underwent TFT check as a screening test for thyroid hormone imbalance not-on-levothyroxine.Methods: TFT test (FT4/TSH) results were taken fro...

ea0092op-08-02 | Oral Session 8: Hypothyrodism / Nodules | ETA2023

Individuals on levothyroxine have higher hads anxiety and depression scores than the general population and this is exacerbated by the THR92ALA substitution in DIO2, particularly at higher doses

Taylor Peter , Haug Eirin , Hanna Stephanie , Heald Adrian , Stedman Mike , Premawardhana Lakdasa , Okosieme Onyebuchi , Olav AEsvold Bjorn , Dayan Colin

Context: Approximately 15% of people with hypothyroidism remain symptomatic despite treatment. The Thr92Ala substitution in DIO2, may influence T3 tissue levels.Methods: We assessed HADS anxiety and depression scores in HUNT2 in 50,901 individuals (6,687 homozygous for Thr92Ala) of whom 1,480 had a history of levothyroxine use (180 homozygous for Thr92Ala). Anxiety and depression caseness (score>=8) by levothyroxine and Thr92Ala status was a...

ea0092op-08-05 | Oral Session 8: Hypothyrodism / Nodules | ETA2023

Thyroid hormone profiles in individuals on non standard thyroid hormone replacement

Taylor Peter , Arooj Aneela , Hanna Stephanie , Eligar Vinay , Muhammed Zubair , Stedman Mike , Premawardhana Lakdasa , Okosieme Onyebuchi , Heald Adrian , Dayan Colin

Context: Up to 15% of people with hypothyroidism remain symptomatic despite treatment with levothyroxine. A proportion of these utilise combination thyroid hormone replacement, T3 monotherapy and desiccated thyroid extract (DTE). We sought to explore thyroid hormone profiles in these patients.Methods: We performed hourly blood tests (8.30am-4.30pm) to assess TSH, T3 and T4 levels in 49 individuals (n =14 combination thyroid hormone replacement, ...

ea0094p128 | Thyroid | SFEBES2023

Thyroid hormone profiles on non-standard thyroid hormone replacement

Taylor Peter , Arooj Aneela , Hanna Stephanie , Eligar Vinay , Muhammad Zubair , Stedman Mike , Premawardhana Lakdasa , Okosieme Onyebuchi , Heald Adrian , Dayan Colin

Context: Approximately 10% of patients on levothyroxine remain symptomatic despite restoration of biochemical euthyroidism. Some therefore utilise alternatives to levothyroxine monotherapy including combination thyroid hormone replacement, T3 monotherapy and desiccated thyroid extract (DTE). We examined thyroid hormone profiles in these patients.Methods: We examined 49 individuals 14 on combination thyroid hormone replac...

ea0099ep361 | Thyroid | ECE2024

Liothyronine (LT3) prescribing in england – are cost constraints inhibiting guideline implementation?

Heald Adrian , Premawardhana Lakdasa , Warner-Levy John , Taylor Peter , Chaudhury Nadia , Okosieme Onyebuchi , Stedman Mike , Dayan Colin

Introduction: Primary hypothyroidism affects about 3% of the general population in Europe. In most cases, people are treated with Levothyroxine. In relation to the recent British Thyroid Association guidance and the 2020 Competitions and Marketing Authority (CMA) ruling, we examined prescribing data for levothyroxine, NDT and liothyronine by dose, regarding changes from 2016 to 2022.Design: Monthly primary care prescribing data for each British National ...

ea0104oc3 | Oral Communications | SFEIES24

The relation of microvascular complications to a new interpretation of glycaemic variability from continuous glucose monitoring in people with type 1 diabetes (T1D)

Heald Adrian , Stedman Mike , Paisley Angela , Warner Levy John , Belston Lleyton , Gibson Martin , Whyte Martin , Habte-Asres Hellena , Forbes Angus

Introduction: Microvascular and macrovascular complications in type 1 diabetes T1D) may be linked to endothelial stress due to glycaemic variability. This work aimed to examine whether determination of glycaemic parameters including glucose variability (GV) over an 18month period is associated with microvascular clinical sequelae. Methods: Freestyle Libre 15-minute glucose values were downloaded for 89 T1DM individuals for up to 18 months from 2021 to 20...